Zimmer Biomet Holdings (ZBH): Accelerating Growth To Market Rates - Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
UBS Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q Earnings Report
August 2, 2016 9:18 AM EDTUBS reiterated a Neutral rating on Zimmer Biomet (NYSE: ZBH), and raised the price target to $132.00 (from $117.00), following the company's 2Q earnings report.
Analyst Matt Miksic commented, "WW sales growth improved in Q2 for most business lines, partially driven by extra selling days (+1.9% WW), and Zimmer Biomet narrowed its gap in... More
